US 11840536
Heterocyclic inhibitors of PTPN11
granted A61KA61K31/4985A61K31/501
Quick answer
US patent 11840536 (Heterocyclic inhibitors of PTPN11) held by The Board of Regents of the University of Texas System expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4985, A61K31/501, A61P, A61P35/00